Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Nov 2021 07:00 AM
RNS
Final Results
28 Oct 2021 03:40 PM
RNS
Notice of Results
11 Oct 2021 07:00 AM
RNS
Director's shareholding
30 Sep 2021 01:00 PM
RNS
Result of General Meeting
29 Sep 2021 07:00 AM
RNS
Result of Open Offer
29 Sep 2021 07:00 AM
RNS
New Genedrive System receives CE-IVD marking
14 Sep 2021 07:00 AM
RNS
Publication of Circular and Notice of GM
10 Sep 2021 05:03 PM
RNS
Result of Placing
10 Sep 2021 04:40 PM
RNS
Second Price Monitoring Extn
10 Sep 2021 04:35 PM
RNS
Price Monitoring Extension
10 Sep 2021 02:01 PM
RNS
Proposed Placing and Open Offer
31 Aug 2021 07:00 AM
RNS
New Genedrive system readied for AIHL launch
01 Jul 2021 07:00 AM
RNS
Genedrive COVID-19 Point of Care device update
25 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
25 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
25 Jun 2021 01:17 PM
RNS
Genedrive confirms receipt of India Import License
25 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
25 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
22 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
22 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
28 May 2021 06:00 PM
RNS
Block listing Interim Review
28 May 2021 04:40 PM
RNS
Second Price Monitoring Extn
28 May 2021 04:35 PM
RNS
Price Monitoring Extension
06 May 2021 02:05 PM
RNS
Second Price Monitoring Extn
06 May 2021 02:00 PM
RNS
Price Monitoring Extension
30 Apr 2021 07:00 AM
RNS
COVID-19 PCR test approved by Indian regulator
23 Apr 2021 07:00 AM
RNS
Excellent performance data for Genedrive® HCV test
19 Apr 2021 07:00 AM
RNS
PHE National Framework Agreement
01 Apr 2021 07:00 AM
RNS
Total Voting Rights
31 Mar 2021 11:05 AM
RNS
Second Price Monitoring Extn
31 Mar 2021 11:00 AM
RNS
Price Monitoring Extension
25 Mar 2021 07:00 AM
RNS
Half-year Report
09 Mar 2021 07:00 AM
RNS
Distribution agreement
03 Mar 2021 07:00 AM
RNS
Antibiotic Induced Hearing Loss update
01 Mar 2021 04:41 PM
RNS
Second Price Monitoring Extn
01 Mar 2021 04:35 PM
RNS
Price Monitoring Extension
01 Mar 2021 07:00 AM
RNS
Investor Presentation
01 Mar 2021 07:00 AM
RNS
Total Voting Rights
17 Feb 2021 07:00 AM
RNS
First US shipments of Genedrive® 96 SARS-CoV-2 Kit
12 Feb 2021 02:10 PM
RNS
Holding(s) in Company
10 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
10 Feb 2021 09:00 AM
RNS
Price Monitoring Extension
09 Feb 2021 02:28 PM
RNS
Holding(s) in Company
08 Feb 2021 03:30 PM
RNS
Holding(s) in Company
08 Feb 2021 12:51 PM
RNS
Holding(s) in Company
08 Feb 2021 11:05 AM
RNS
Second Price Monitoring Extn
08 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
02 Feb 2021 02:05 PM
RNS
Holding(s) in Company
02 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
02 Feb 2021 09:00 AM
RNS
Price Monitoring Extension

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings